De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signaling pathway - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Histopathology Année : 2010

De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signaling pathway

Raphaela Fritsche
  • Fonction : Auteur correspondant
  • PersonId : 903938

Connectez-vous pour contacter l'auteur
Aurelia Noske
  • Fonction : Auteur
  • PersonId : 903940
Ute Ungethüm
  • Fonction : Auteur
  • PersonId : 903965
Ralf-Jürgen Kuban
  • Fonction : Auteur
  • PersonId : 903966
Peter M Schlag
  • Fonction : Auteur
  • PersonId : 903942
Per-Ulf Tunn
  • Fonction : Auteur
  • PersonId : 889274
Janine Karle
  • Fonction : Auteur
  • PersonId : 903967
Veit Jonas Krenn
  • Fonction : Auteur
  • PersonId : 903944
Manfred Dietel
  • Fonction : Auteur
  • PersonId : 903968

Résumé

Aims: In osteosarcoma patients, the development of metastases, often to the lungs, is the most frequent cause of death. To improve this situation, a deeper understanding of the molecular mechanisms governing osteosarcoma development and dissemination and the identification of novel drug targets for an improved treatment are needed. Methods and results: Towards this aim, we characterized osteosarcoma samples using genome-wide microarrays and detected increased expression of the EphA2 receptor and its ligand EFNA1 in osteosarcoma tissues. In addition, increased expression of EFNB1, EFNB3 and EphA3 was suggested. Immunohistochemical staining revealed an absence of EphA2 from normal bone, and de novo expression in osteosarcomas. EFNA1 was expressed in normal bone, but significantly elevated in tumors. This pattern suggests a specific role for the EFNA1-EphA2-interaction in osteosarcoma. Further in vitro investigations on the functional role of EphA2 and EFNA1 showed that EFNA1 ligand binding induced increased tyrosine phoshorylation, receptor degradation and downstream MAPK activation. Interference with the MAPK pathway unraveled a potential autoregulatory loop governing mainly EFNA1 expression via the same pathway. Conclusion: Our results indicate that upregulation and de novo expression of ephrins in osteosarcomas are involved in oncogenic signaling and thus might stimulate osteosarcoma metastasis.

Mots clés

Fichier principal
Vignette du fichier
PEER_stage2_10.1111%2Fj.1365-2559.2010.03713.x.pdf (2.24 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-00601183 , version 1 (17-06-2011)

Identifiants

Citer

Raphaela Fritsche, Aurelia Noske, Ute Ungethüm, Ralf-Jürgen Kuban, Peter M Schlag, et al.. De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signaling pathway. Histopathology, 2010, 57 (6), pp.836. ⟨10.1111/j.1365-2559.2010.03713.x⟩. ⟨hal-00601183⟩

Collections

PEER
144 Consultations
445 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More